Literature DB >> 16508440

Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.

John O Mason1, Michael A Albert, Rachel Vail.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508440     DOI: 10.1097/00006982-200603000-00018

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  26 in total

1.  Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors:  P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

2.  Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Authors:  M S Spitzer; B Wallenfels-Thilo; A Sierra; E Yoeruek; S Peters; S Henke-Fahle; K U Bartz-Schmidt; P Szurman
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

3.  Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.

Authors:  María Rodríguez-Blanco; Joaquin Marticorena; Francisco Gómez-Ulla
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-19       Impact factor: 3.117

4.  Application of intravitreal bevacizumab for circumscribed choroidal hemangioma.

Authors:  Min Sagong; Junyeop Lee; Woohyok Chang
Journal:  Korean J Ophthalmol       Date:  2009-06-09

5.  Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema.

Authors:  Ayse Gul Kocak Altintas; Cagri Ilhan
Journal:  Korean J Ophthalmol       Date:  2019-06

6.  Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.

Authors:  Yosuke Sugimoto; Hideki Mochizuki; Hideaki Okumichi; Masaya Takumida; Michiya Takamatsu; Seiichi Kawamata; Yoshiaki Kiuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-04       Impact factor: 3.117

7.  Pattern electroretinogram changes after intravitreal bevacizumab injection for diabetic macular edema.

Authors:  Abdullah Ozkiriş
Journal:  Doc Ophthalmol       Date:  2010-02-07       Impact factor: 2.379

8.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Intravitreal bevacizumab injection and carotid artery stent replacement for neovascular glaucoma in internal carotid artery occlusion.

Authors:  Aya Kodama; Koji Sugioka; Kazuki Kuniyoshi; Sachiko Okuyama; Chota Matsumoto; Yoshikazu Shimomura
Journal:  Clin Ophthalmol       Date:  2010-10-21

10.  Acute bacterial endophthalmitis after intravitreal bevacizumab injection: Case report and literature review.

Authors:  Saba Al Rashaed; Abdulaziz Rushood
Journal:  Saudi J Ophthalmol       Date:  2012-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.